je.st
news
Home
› Ipsen Announces A Step Forward In The Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S.
Ipsen Announces A Step Forward In The Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S.
2014-05-16 10:04:38| foodingredientsonline Home Page
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced that a supply of Increlex (mecasermin [rDNA origin] injection) will be available in the U.S. starting June 2, 2014
Tags: the
us
step
forward
Category:Food and Related Products
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||